Model
Edge
Moonlake Immunotherapeutics
MLTX
Filing Type
8-K
Filing Date
6/8/2026
Updated
6/9/26, 2:55 PM
Copy Ref
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation, Shareholder votes
EX-10.1
MOONLAKE IMMUNOTHERAPEUTICS AMENDED AND RESTATED 2022 EQUITY INCENTIVE PLAN